From CEO interview last week that they are investigating the drug for kidney disease indication. TRPC 3,6 like the brain and heart also all over the kidney. NYR-BO3 will have an added indication in reducing necrosis of the kidney in the coming period ahead. Ischemic Kidney injury is a 11 billion dollar market. Bought more again today and this rubbish 19 million market cap will become a 100 million dollar plus market cap like its peers but will have cardiovascular and kidney disease indications
Ann: Change of Registered Office and Principal Place of Business, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.010(4.55%) |
Mkt cap ! $48.51M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.0¢ | 22.5¢ | $35.32K | 155.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 50012 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 106360 | 1 |
View Market Depth
| Last trade - 14.38pm 25/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |